Last checked at 23 Feb 2021 12:18
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 22 February 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
2,035,439 | 1.58% | 383,076 | 0.30% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
153,127 | 0.12% | 240,989 | 0.19% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,000 | 0.00% | 6,000 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
2,194,566 | 1.70% | 630,065 | 0.49% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 1 | 225.0000 USD |
| Purchase | 7 | 225.1828 USD |
| Purchase | 7 | 225.0786 USD |
| Purchase | 11 | 224.9400 USD |
| Purchase | 25 | 225.3900 USD |
| Purchase | 40 | 225.3600 USD |
| Purchase | 50 | 225.3800 USD |
| Purchase | 89 | 225.4496 USD |
| Purchase | 100 | 224.8600 USD |
| Purchase | 121 | 225.3205 USD |
| Purchase | 144 | 224.9165 USD |
| Purchase | 150 | 225.0266 USD |
| Purchase | 169 | 225.2630 USD |
| Purchase | 199 | 225.3590 USD |
| Purchase | 300 | 225.3500 USD |
| Purchase | 400 | 225.1587 USD |
| Purchase | 586 | 225.1299 USD |
| Purchase | 952 | 224.9192 USD |
| Purchase | 994 | 224.9456 USD |
| Purchase | 994 | 224.9455 USD |
| Purchase | 1,200 | 225.2399 USD |
| Purchase | 2,530 | 225.1243 USD |
| Purchase | 2,907 | 225.1740 USD |
| Purchase | 3,783 | 225.1634 USD |
| Purchase | 7,419 | 225.1151 USD |
| Purchase | 12,824 | 225.2428 USD |
| Purchase | 13,240 | 225.0212 USD |
| Purchase | 13,618 | 225.0062 USD |
| Purchase | 28,276 | 225.0324 USD |
| Purchase | 102,625 | 224.9004 USD |
| Purchase | 108,853 | 224.9000 USD |
| Sale | 1 | 225.2800 USD |
| Sale | 1 | 225.2600 USD |
| Sale | 2 | 225.1700 USD |
| Sale | 25 | 225.3900 USD |
| Sale | 49 | 224.9500 USD |
| Sale | 87 | 225.4600 USD |
| Sale | 100 | 224.9900 USD |
| Sale | 100 | 224.7300 USD |
| Sale | 100 | 224.8100 USD |
| Sale | 200 | 225.1900 USD |
| Sale | 238 | 224.7843 USD |
| Sale | 256 | 225.5798 USD |
| Sale | 294 | 224.8823 USD |
| Sale | 302 | 225.1451 USD |
| Sale | 437 | 225.1458 USD |
| Sale | 488 | 224.9858 USD |
| Sale | 493 | 224.9178 USD |
| Sale | 700 | 224.9721 USD |
| Sale | 710 | 225.1486 USD |
| Sale | 916 | 224.9789 USD |
| Sale | 952 | 224.9192 USD |
| Sale | 994 | 224.9455 USD |
| Sale | 1,037 | 224.9839 USD |
| Sale | 1,200 | 225.2399 USD |
| Sale | 1,369 | 224.9023 USD |
| Sale | 1,820 | 225.0701 USD |
| Sale | 3,124 | 225.1192 USD |
| Sale | 4,295 | 225.1032 USD |
| Sale | 4,927 | 224.9272 USD |
| Sale | 5,839 | 224.8999 USD |
| Sale | 8,326 | 224.9723 USD |
| Sale | 10,000 | 225.1619 USD |
| Sale | 10,352 | 225.1347 USD |
| Sale | 11,723 | 225.0187 USD |
| Sale | 12,669 | 224.9952 USD |
| Sale | 12,845 | 225.2718 USD |
| Sale | 102,476 | 224.9000 USD |
| Sale | 102,626 | 224.9004 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 23 Feb 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
purchased | relevant securities | price |
| date | |
| to which the option |
|
|
| |
| or derivative |
|
|
| |
| relates |
|
|
| |
| Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
| Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210223005641/en/
Copyright Business Wire 2021